Released · Last reviewed
Sildenafil telehealth providers: how to evaluate them
Sildenafil is a PDE5 inhibitor, FDA-approved for erectile dysfunction and (as Revatio) for pulmonary arterial hypertension. It has a shorter half-life than tadalafil — roughly 4 hours — giving an effective window of about 4 to 6 hours, and it works best taken on an empty stomach. It is available as a low-cost generic.
How to evaluate a Sildenafil provider
We do not publish a ranked list of Sildenafil providers, for a specific reason: we have not captured and dated their pricing or verified their pharmacy relationships. Publishing a ranking we cannot substantiate would be worth less than nothing.
What we can give you is the evaluation framework we apply to the providers we have verified — the 19 GLP-1 telehealth companies in our pricing database.
| Signal | What good looks like | What should worry you |
|---|---|---|
| Prescribing clinician | Named, licensed, verifiable NPI | Unnamed 'medical team' |
| Medical evaluation | Real review; some patients are declined | A form that approves everyone |
| Pharmacy | Named facility, licence verifiable in a state board database | 'Our network of licensed pharmacies' |
| Formulation | Salt form and concentration disclosed | Will not tell you |
| Regulatory language | States plainly that compounded is not FDA-approved | 'FDA-approved pharmacy' — a meaningless phrase |
| Evidence claims | Distinguishes mechanism from demonstrated outcome | Cites mouse studies as if they were human results |
| Pricing | Total cost stated up front, cancellation terms published | Headline rate that turns out to be a first month |
How to verify any of this yourself
You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.
- Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
- Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
- Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
- Ask what the highest dose costs. By email or chat, so you have it in writing.
- Ask about early cancellation before you commit to a plan longer than a month.
- Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.
If a provider will not answer questions 4 or 5 in writing, that is itself information.
Frequently asked questions
What does Sildenafil cost through telehealth?
It is available as an inexpensive FDA-approved generic — price that at a pharmacy before paying a subscription for a compounded version.
Is Sildenafil FDA-approved?
Sildenafil is FDA-approved and available as an inexpensive generic. As with tadalafil, there is rarely a good reason to pay more for a compounded troche, a 'proprietary blend' or a stacked combination product. Those are not FDA-approved and have no demonstrated adva
Does Sildenafil work?
Extensively studied and clearly effective for erectile dysfunction across large randomised trials, with decades of post-marketing data. Along with tadalafil, this is among the best-evidenced treatments covered on this site.
Sources
- U.S. Food and Drug Administration — approved labels and compounding guidance for this molecule.
- PubMed / NIH — indexed human clinical literature.
- ClinicalTrials.gov — registered trials, where they exist.
- Our source hierarchy and pricing-verification methodology.
The numbers behind this page
Checking the figures in this page
Every price quoted in this page comes from the programme's own pricing page and carries the date it was captured. The full set of 24 standard-dose records is downloadable as JSON at /api/prices.json, with molecule and dose class stated on every record. Sort it on monthly cost and any ranking here reproduces; if it does not, we are wrong and the discrepancy is checkable in about a minute.
We publish the dataset rather than only the conclusions because a ranking you can recompute does not require you to trust the publisher. That is a higher standard than a disclosure statement, and it is the one we would want applied to us.
Reading the price against the market
Where this sits in the market
The figures in this page sit inside a market with a measurable shape, and that shape is what makes any single price readable.
21 programmes print a price for both molecules on their own pages. Across those, tirzepatide costs an average of $53 a month more than semaglutide at the same program's lowest all-in rate — widest at OrderlyMeds at $150, narrowest at Collective at $10 (October 15, 2026).
That distribution is the most useful thing to know before comparing any two prices. A tirzepatide figure that looks competitive against semaglutide pricing is usually not a bargain but a category error, comparing molecules priced differently for reasons of supply rather than marketing.
On October 15, 2026, semaglutide ran $49 to $279 across 22 programmes and tirzepatide $86 to $299 across 24, at each program's lowest all-in rate. Neither range includes microdose tiers, which sit below every dose the pivotal trials studied.
Questions this page answers
Where do these prices come from?
Each is read from the program's own pricing page and carries its read date. The October 15, 2026 file at /api/prices.json holds 106 records, 49 of them verified standard-dose prices, with molecule, dose class and evidence status on every record.
Which tracked programs charge less than NexLife?
Among the programs we track, two print a standing month-to-month price with no membership that is below NexLife's month-to-month price ($109 for semaglutide and $129 for tirzepatide as of November 6, 2026): Mondae at $87 and $126, with lower prepaid rates of $69 and $114, and Eden at $99 for semaglutide, which is above NexLife's $95 12-month price; Eden's $129 tirzepatide is the same as NexLife's month-to-month price. Competitor prices were read on October 15, 2026. Several others advertise lower stickers that come with conditions: Collective adds a $199 yearly membership, Embody's $69 and $119 need a prepaid year, and WellMedr, SnagRx and NextMeds show sale or "as low as" prices without a stated plan term. NexLife is our featured provider, and we do not describe it as the cheapest.
Are compounded GLP-1 medicines FDA-approved?
No. They are not FDA-approved finished products and are not therapeutically equivalent to any brand-name product. FDA does not review them for safety, effectiveness or manufacturing quality before marketing.
Why do the same programmes quote two different prices?
Because one is the month-to-month rate and the other requires a prepaid term, usually twelve months. We compare programs on their lowest all-in monthly price and print the plan term beside every figure, so a rate that needs a commitment is labelled as one.